Search results for: 'Cancer Diagnostics Market'
- Related search terms
- market analysis of rf energy harvesting technolog
- marketing strategy homes industry year 16.9
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
22 Dec 2019  |  North America  |  Technology Research
Imaging Innovations for Breast Cancer Diagnosis
Advances in Digital Technologies Enabling Early and Accurate Disease Diagnosis in FemTech Industry
The leading cause of cancer deaths in women globally is breast cancer. Regular breast cancer screening is imperative for early detection and timely intervention. Screening mammography is the method most commonly used worldwide for the detection of breast cancer. However, the traditional methods of screening are plagued by several challenges. Over t...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Feb 2023  |  North America  |  Market Research
Growth Opportunities in the Global Cloud-based Medical Imaging Informatics Market, Forecast to 2026
Conventional Medical Imaging Informatics Shifts to AI-based Consolidated Solutions
Medical imaging informatics solution deployment is shifting from the on-premises model to a cloud-based infrastructure. The conventional on-premises model, which requires every enterprise to buy, operate, and maintain its own cumbersome IT infrastructure and solutions, proves unsustainable in the era of big data. It is also short-sighted given the ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Dec 2013  |  North America  |  Market Research
Analysis of the Global Tissue Diagnostics Market
Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories
This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forec...
$10,000.00
Special Price $7,500.00 save 25 %
-
29 Apr 2006  |  North America  |  Market Research
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Sep 2014  |  North America  |  Market Research
Analysis of the Global Infectious Disease Diagnostics Market
Molecular Methods Present Significant Opportunities
This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...
$3,950.00
Special Price $2,962.50 save 25 %
-
10 Mar 2015  |  North America  |  Market Research
The US Blood Transfusion Diagnostics Market
Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand
This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Growth Spurred by Simple and Accurate Point of Care (POC) Testing at Home for Urological Conditions such as Nephrolithiasis and Urinary Tract Infections (UTIs)
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00
Special Price $1,125.00 save 25 %
-
15 Mar 2003  |  North America  |  Market Research
U.S. Point-Of-Care Retail Diagnostics Markets
The U.S. Point-of-Care Retail Diagnostic report focuses on the largest segments of this market, pregnancy and ovulation. This report includes revenues and market share information, as well as a forecast to 2009, using 2002 as the base year. The study includes detailed analysis of market trends, challenges, drivers, strategies, pricing and demand....
$2,450.00
Special Price $1,837.50 save 25 %
-
29 May 2019  |  North America  |  Market Research
Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022
Improved Accuracy for Localization of Radiotherapy Treatment to Drive the Demand for Fiducial Markers
15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease ma...
$1,500.00
Special Price $1,125.00 save 25 %